search
Back to results

A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism (PRT-C)

Primary Purpose

Autism Spectrum Disorder, Autism

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Intensive Center-Based Pivotal Response Treatment (PRT-C)
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Autism Spectrum Disorder focused on measuring Pivotal Response Treatment

Eligibility Criteria

2 Years - 3 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of Autism Spectrum Disorder (ASD) based on clinical interview and Diagnostic and Statistical Manual, 5th edition (DSM-5) and confirmed using the Autism Diagnostic Interview Revised (ADI-R) and Autism Diagnostic Observation Schedule, 2nd edition (ADOS-2) or Childhood Autism Rating Scale (CARS-2); Diagnostic and Statistical Manual, 5th edition (DSM-5), and expert clinical opinion
  • Boys and girls between 2 years and 3 years and 11 months
  • Ability to participate in the testing procedures to the extent that valid standard scores can be obtained
  • Stable treatment (e.g., applied behavior analysis (ABA), speech therapy, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation
  • Developmentally delayed with Mullen Scales of Early Learning (MSEL) or Developmental Profile (DP-4) composite score below 85 (1 Standard Deviation below the mean)
  • Availability of at least one English-speaking parent who can consistently participate in parent training and research measures.

Exclusion Criteria:

  • Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.)
  • Presence of active medical problem (e.g., unstable seizure disorder or heart disease)
  • Child primary language other than English
  • Previous adequate trial of Pivotal Response Treatment
  • More than 15 hours per week of in-home applied behavior analysis (ABA).

Sites / Locations

  • Stanford University School of MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intensive Center-Based Pivotal Response Treatment (PRT-C)

Delayed Treatment Group (DTG)

Arm Description

Intensive Center-Based Pivotal Response Treatment (PRT-C) will consist of a combination of one weekly 60-minute individual parent training session and 12 weekly hours ( 3 hours per day for 4 days per week) with the child in center-based therapy environment for a total of 13 weekly treatment hours.

Delayed Treatment Group will consist of treatment as usual. At the end of controlled phase, participants in the DTG will be offered PRT-C in a preschool setting in an open-label fashion with a design similar to the double-blind phase.

Outcomes

Primary Outcome Measures

Mean Change from baseline on the Social Responsiveness Scale-2 Total Score at 12 Weeks
Mean change from baseline on the Brief Observation of Communication Change (BOSCC) total score at 12 Weeks
Mean change from baseline on the frequency if the child's functional utterances on the structured lab observation at 12 Weeks

Secondary Outcome Measures

Mean change from baseline on the Vineland Adaptive Behavior Scales 3rd Edition Socialization subscale at 12 Weeks
Mean change from baseline on the MacArthur-Bates Communication Development Inventory at 12 Weeks

Full Information

First Posted
December 15, 2018
Last Updated
March 2, 2023
Sponsor
Stanford University
Collaborators
John & Marcia Goldman Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT03778827
Brief Title
A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism
Acronym
PRT-C
Official Title
A Center Based Randomized Controlled Trial of Pivotal Response Treatment for Preschoolers With Autism
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 8, 2019 (Actual)
Primary Completion Date
March 2025 (Anticipated)
Study Completion Date
March 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
Collaborators
John & Marcia Goldman Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to examine the effectiveness of pivotal response training (PRT) in an intensive center-based environment to treat social communication deficits in children with autism spectrum disorder (ASD).
Detailed Description
The purpose of this study is to examine the effectiveness of pivotal response training (PRT) in an intensive center-based preschool environment to treat social communication deficits in children with autism spectrum disorder (ASD). The study will compare Pivotal Response Treatment (PRT) to a delayed treatment group (DTG). PRT is a naturalistic behavioral intervention based on the principles of applied behavior analysis which has shown to be effective in treating the core deficits in children with ASD. The study will compare the combination of parent training with intensive center-based PRT (PRT-C) to a DTG and will include 44 children ages 2 to 3.11 years with ASD and social communication deficits.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autism Spectrum Disorder, Autism
Keywords
Pivotal Response Treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
44 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intensive Center-Based Pivotal Response Treatment (PRT-C)
Arm Type
Experimental
Arm Description
Intensive Center-Based Pivotal Response Treatment (PRT-C) will consist of a combination of one weekly 60-minute individual parent training session and 12 weekly hours ( 3 hours per day for 4 days per week) with the child in center-based therapy environment for a total of 13 weekly treatment hours.
Arm Title
Delayed Treatment Group (DTG)
Arm Type
No Intervention
Arm Description
Delayed Treatment Group will consist of treatment as usual. At the end of controlled phase, participants in the DTG will be offered PRT-C in a preschool setting in an open-label fashion with a design similar to the double-blind phase.
Intervention Type
Behavioral
Intervention Name(s)
Intensive Center-Based Pivotal Response Treatment (PRT-C)
Intervention Description
Intensive Center-Based Pivotal Response Treatment (PRT-C) will consist of a combination of weekly individual parent training sessions and center-based therapy for a total of 13 weekly treatment hours.
Primary Outcome Measure Information:
Title
Mean Change from baseline on the Social Responsiveness Scale-2 Total Score at 12 Weeks
Time Frame
Baseline and Week 12
Title
Mean change from baseline on the Brief Observation of Communication Change (BOSCC) total score at 12 Weeks
Time Frame
Baseline and Week 12
Title
Mean change from baseline on the frequency if the child's functional utterances on the structured lab observation at 12 Weeks
Time Frame
Baseline and Week 12
Secondary Outcome Measure Information:
Title
Mean change from baseline on the Vineland Adaptive Behavior Scales 3rd Edition Socialization subscale at 12 Weeks
Time Frame
Baseline and Week 12
Title
Mean change from baseline on the MacArthur-Bates Communication Development Inventory at 12 Weeks
Time Frame
Baseline and Week 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
3 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of Autism Spectrum Disorder (ASD) based on clinical interview and Diagnostic and Statistical Manual, 5th edition (DSM-5) and confirmed using the Autism Diagnostic Interview Revised (ADI-R) and Autism Diagnostic Observation Schedule, 2nd edition (ADOS-2) or Childhood Autism Rating Scale (CARS-2); Diagnostic and Statistical Manual, 5th edition (DSM-5), and expert clinical opinion Boys and girls between 2 years and 3 years and 11 months Ability to participate in the testing procedures to the extent that valid standard scores can be obtained Stable treatment (e.g., applied behavior analysis (ABA), speech therapy, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation Developmentally delayed with Mullen Scales of Early Learning (MSEL) or Developmental Profile (DP-4) composite score below 85 (1 Standard Deviation below the mean) Availability of at least one English-speaking parent who can consistently participate in parent training and research measures. Exclusion Criteria: Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.) Presence of active medical problem (e.g., unstable seizure disorder or heart disease) Child primary language other than English Previous adequate trial of Pivotal Response Treatment More than 15 hours per week of in-home applied behavior analysis (ABA).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Madeleine Clark, BS
Phone
(650)736-1235
Email
mclark11@stanford.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Estefania Millan, MA
Phone
(650)736-1235
Email
mmillan2@stanford.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Antonio Y. Hardan, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University School of Medicine
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Madeleine Clark, BS
Phone
650-736-1235
Email
mclark11@stanford.edu
First Name & Middle Initial & Last Name & Degree
Estefania Millan, MA
Phone
(650)736-1235
Email
mmillan2@stanford.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism

We'll reach out to this number within 24 hrs